Abeona on SPi NewsFollow our SPi News RSS Feed for abeona

Featured abeona News

[10 May 2019] Abeona Therapeutics Reports First Quarter 2019 Financial Results and Business Highlights

[08 May 2019] Abeona Therapeutics Announces Presentation of EB-101 Data at Society for Investigative Dermatology Annual Meeting

[07 May 2019] Abeona Therapeutics Announces Participation in Upcoming Investor Conferences

[18 Mar 2019] Abeona Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results

[22 Feb 2019] Abeona Therapeutics Announces Participation in 8th Annual SVB Leerink Global Healthcare Conference

[11 Feb 2019] Abeona Therapeutics Appoints João Siffert, M.D. Chief Executive Officer

[31 Jan 2019] Abeona Therapeutics to Present New Supportive Data for Novel Gene Therapies at WORLDSymposium™

[08 Jan 2019] Abeona Therapeutics Strengthens Financial Leadership with New Executive Appointments

[29 Nov 2018] Abeona Therapeutics to Host R&D Day on December 6, 2018

[26 Nov 2018] Abeona Therapeutics Announces CEO Transition

[13 Nov 2018] Abeona Announces Participation at the Jefferies 2018 London Healthcare Conference

[09 Nov 2018] Abeona Therapeutics Reports Third Quarter 2018 Financial Results and Business Highlights

[28 Sep 2018] Abeona Announces Participation at Upcoming Conferences

[04 Sep 2018] Abeona Announces Participation at Upcoming Conferences

[09 Aug 2018] Abeona Therapeutics Reports Second Quarter 2018 Financial Results and Business Highlights

[26 Jul 2018] Abeona Therapeutics Announces Leadership Appointments with Max Colao as Chief Commercial Officer

[11 May 2018] Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights

[11 May 2018] Abeona Therapeutics Reports First Quarter 2018 Financial Results and Business Highlights

[08 May 2018] Abeona Therapeutics Announces Upcoming Presentations

[23 Apr 2018] Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

[23 Apr 2018] Abeona Announces FDA Grants RMAT Designation to ABO-102 Gene Therapy in MPS IIIA

[02 Apr 2018] Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer

[02 Apr 2018] Abeona Therapeutics Appoints Carsten Thiel, Ph.D., as Chief Executive Officer

[16 Mar 2018] Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights

[16 Mar 2018] Abeona Therapeutics Reports Fourth Quarter 2017 Financial Results and Business Highlights

[21 Feb 2018] Abeona Therapeutics Announces Upcoming Conference Participation

[08 Feb 2018] Abeona Therapeutics Reports Top-Line Data from Phase 1/2 Gene Therapy Trial in MPS IIIA

[02 Feb 2018] Abeona Therapeutics Announces Upcoming Presentations at the 14th Annual WORLDSymposium

[02 Feb 2018] Abeona Therapeutics Announces Upcoming Presentations at the 14th Annual WORLDSymposium

[20 Dec 2017] Abeona Therapeutics Enrolls First Patient in ABO-101 Phase 1/2 Clinical Trial for MPS IIIB

[15 Nov 2017] Abeona Reports Third Quarter 2017 Financial Results and Recent Business Highlights

[13 Nov 2017] Abeona Management to Present at Multiple Conferences in November

[13 Nov 2017] Abeona Management to Present at Multiple Conferences in November

[09 Nov 2017] Abeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIA

[09 Nov 2017] Abeona Enrolls First Subject in Spain in Ongoing Phase 1/2 Clinical Trial in MPS IIIA

[28 Sep 2017] Abeona Therapeutics and Brammer Bio Announce Collaboration for Commercial Translation of ABO-102

[25 Jul 2017] Abeona Therapeutics Announces Appointment of Juan Ruiz as Chief Medical Officer

[16 May 2017] Abeona Therapeutics Reports First Quarter 2017 Financial Results and Recent Business Highlights

[20 Apr 2017] Abeona to Present At Multiple Upcoming Conferences

[05 Apr 2017] Abeona Announces Rare Disease Gene Therapy Symposium with the New York Academy of Sciences

[31 Mar 2017] Abeona Therapeutics Reports Q4 2016 Financial Results and Business Highlights

[13 Mar 2017] Abeona Therapeutics to Present at Multiple Upcoming Investor Conferences

[03 Mar 2017] Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai

[03 Mar 2017] Abeona Therapeutics to Present at Maxim Group LLC Biotech Investor & Partnering Conference in Shanghai

[23 Feb 2017] Abeona Therapeutics Announces Dismissal of Securities Class Action Lawsuit

[23 Feb 2017] Abeona Therapeutics Announces Dismissal of Securities Class Action Lawsuit

[07 Feb 2017] Abeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium(TM) 2017

[07 Feb 2017] Abeona Therapeutics Announces Presentations and Posters at the 13th Annual WORLDSymposium™ 2017

[18 Jan 2017] Lawsuit for Investors in shares of Abeona Therapeutics Inc (NASDAQ:ABEO) announced by Shareholders Foundation

[17 Jan 2017] Abeona Therapeutics to Present at Phacilitate Cell & Gene Therapy World 2017


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

Publish Your Stories with SPI

Please click here to find out how to submit press releases and articles for publication.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2020. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us